Michael Andreeff

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-1144-1958

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 72 papers. Top paper: “10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial”.

10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30210-6

N/A

6.4DataRank · unranked

334 citations

Abhishek Maiti, Caitlin R. Rausch, Naveen Pemmaraju, Kiran Naqvi, Naval Daver +34 more

Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia

Blood Advances(2021)10.1182/bloodadvances.2020003717

N/A

3.2DataRank · unranked

82 citations

Courtney D. DiNardo, Sa A. Wang, Jeffrey L. Jorgensen, Tapan M. Kadia, Naval Daver +28 more

Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy

Blood Cancer Journal(2022)10.1038/s41408-021-00604-2

N/A

2.5DataRank · unranked

95 citations

Koichi Takahashi, Naval Daver, Abhishek Maiti, Gautam Borthakur, Sanam Loghavi +14 more

Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy

Nature Medicine(2022)10.1038/s41591-022-01696-4

N/A

2.2DataRank · unranked

83 citations

Hui Yang, Feiyang Ma, Guillermo Montalban‐Bravo, Natthakan Thongon, Valentina Marchica +33 more

A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents

Journal of Hematology & Oncology(2023)10.1186/s13045-023-01476-8

N/A

1.3DataRank · unranked

51 citations

Muharrem Müftüoğlu, Faustine Ong, Lewis Nasr, Walid Macaron, Guillermo Montalban‐Bravo +22 more

Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics

Blood Cancer Journal(2023)10.1038/s41408-023-00830-w

N/A

0.968DataRank · unranked

31 citations

Po Yee Mak, Wenjing Tao, Edward Ayoub, Lauren B. Ostermann, Xuelin Huang +11 more

The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and Aurora kinases

Research Square(2023)10.21203/rs.3.rs-2570204/v1

N/A

0.136DataRank · unranked

1 citations

Weiguo Zhang, Hongying Zhang, Charlie Ly, Mahesh Basyal, William G. Rice +2 more

FLT3 inhibitors upregulate CXCR4 and E-selectin ligands through suppression of ERK in AML and combined inhibition of CXCR4/E-selectin enhances anti-leukemia efficacy of FLT3-targeted therapy

Research Square(2022)10.21203/rs.3.rs-2277452/v1

N/A

0.104DataRank · unranked

1 citations

Weiguo Zhang, Mahesh Basyal, Kyung Hee Chang, Lauren B. Ostermann, Jared K. Burks +11 more

Omacetaxine and venetoclax in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome with mutant RUNX1

Blood Neoplasia(2025)10.1016/j.bneo.2025.100145

N/A

0.104DataRank · unranked

1 citations

Wei‐Ying Jen, Guillermo Montalban‐Bravo, Xuemei Wang, Sanam Loghavi, Sravanthi Lavu +15 more

Clonal Evolution of Acute Myeloid Leukemia Revealed by High-Throughput Single-Cell Genomics

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.02.07.925743

N/A

0DataRank · unranked

67 citations

Feng Wang, Katharina Jahn, Jack Kuipers, Yuanqing Yan, Jairo Matthews +22 more

Ten-day decitabine with venetoclax (DEC10-VEN) in AML and high-risk (HR) MDS.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7519

N/A

0DataRank · unranked

8 citations

Courtney D. DiNardo, Naveen Pemmaraju, Tapan M. Kadia, Caitlin R. Rausch, Kiran Naqvi +15 more

Bone marrow stromal cells induce an ALDH + stem cell-like phenotype in AML cells through TGF-β-p38-ALDH2 pathway

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.10.197178

N/A

0DataRank · unranked

4 citations

Fouad El Dana, Stanley Ly, Yuanqing Yan, Vivian Ruvolo, Elizabeth J. Shpall +4 more

Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements

Blood Cancer Journal(2021)10.1038/s41408-021-00557-6

N/A

0DataRank · unranked

99 citations

Jabra Zarka, Koji Sasaki, Wei Qiao, Daewoo Pak, Jing Ning +16 more

Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001197

N/A

0DataRank · unranked

51 citations

Vivek Anand, Fouad El-Dana, Khoa Nguyen, Yiming Cai, Shirong Cai +6 more

DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia

Scientific Reports(2021)10.1038/s41598-021-90500-3

N/A

0DataRank · unranked

33 citations

Yuki Nishida, Michael I. Carr, Rafael Heinz Montoya, Lauren B. Ostermann, Weiguo Zhang +5 more

AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemia

Haematologica(2021)10.3324/haematol.2021.278369

N/A

0DataRank · unranked

32 citations

Huaxian Ma, Prerna Malaney, Xiaorui Zhang, Marisa J.L. Aitken, Po Yee Mak +12 more

Extended live-cell barcoding approach for multiplexed mass cytometry

Scientific Reports(2021)10.1038/s41598-021-91816-w

N/A

0DataRank · unranked

23 citations

Li Li, Shaoheng Liang, Duncan H. Mak, Angelique Lin, Junxiang Fang +4 more

Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis

Blood Cancer Journal(2021)10.1038/s41408-021-00446-y

N/A

0DataRank · unranked

10 citations

Guillermo Montalban‐Bravo, Panagiotis Katsonis, Koji Sasaki, Caleb A. Class, Elias Jabbour +26 more

Phase 2 study of lenalidomide maintenance for patients with high‐risk acute myeloid leukemia in remission

Cancer(2021)10.1002/cncr.33409

N/A

0DataRank · unranked

10 citations

Hagop M. Kantarjian, Farhad Ravandi, Naval Daver, Xuemei Wang, Elias Jabbour +16 more

Author Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

Nature Communications(2021)10.1038/s41467-021-23280-z

N/A

0DataRank · unranked

7 citations

Feng Wang, Katharina Jahn, Tianyuan Hu, Tomoyuki Tanaka, Yuya Sasaki +28 more

Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

Signal Transduction and Targeted Therapy(2022)10.1038/s41392-021-00870-3

N/A

0DataRank · unranked

186 citations

Bridget Riley‐Gillis, Lina Han, Yannan Jia, Alessia Lodi, Haijiao Zhang +36 more

Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia

Nature Communications(2022)10.1038/s41467-022-30396-3

N/A

0DataRank · unranked

63 citations

Alessia Lodi, Yogesh Dhungana, Shelley M. Herbrich, Meghan Collins, Shannon Sweeney +50 more

Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML

Blood Advances(2022)10.1182/bloodadvances.2022008316

N/A

0DataRank · unranked

56 citations

Aram Bidikian, Sangeetha Venugopal, Marina Konopleva, Courtney D. DiNardo, Tapan M. Kadia +20 more

Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL

Leukemia(2022)10.1038/s41375-022-01516-1

N/A

0DataRank · unranked

32 citations

Ya‐Ling Yang, Seemana Bhattacharya, Priyanka Sharma, Huaxian Ma, Hong Mu +11 more

In-depth analysis of SARS-CoV-2–specific T cells reveals diverse differentiation hierarchies in vaccinated individuals

JCI Insight(2022)10.1172/jci.insight.156559

N/A

0DataRank · unranked

28 citations

Muharrem Müftüoğlu, Shaoheng Liang, Mahesh Basyal, Jiangxing Lv, Mehmet Emin Akdogan +5 more

Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy

Haematologica(2022)10.3324/haematol.2022.280884

N/A

0DataRank · unranked

28 citations

Guopan Yu, Hongying Zhang, Mahesh Basyal, Charlie Ly, Bin Yuan +10 more

Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX Models

Frontiers in Immunology(2022)10.3389/fimmu.2022.880108

N/A

0DataRank · unranked

20 citations

Lauren B. Ostermann, Muharrem Müftüoğlu, Abishek Vaidya, Challice L. Bonifant, Mireya Paulina Velasquez +3 more

Maximal Activation of Apoptosis Signaling by Cotargeting Antiapoptotic Proteins in BH3 Mimetic–Resistant AML and AML Stem Cells

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0690

N/A

0DataRank · unranked

16 citations

Po Yee Mak, Wenjing Tao, Qi Zhang, Vivian Ruvolo, Vinitha M. Kuruvilla +10 more

SOHO State of the Art Updates and Next Questions | Beyond BCL-2 Inhibition in Acute Myeloid Leukemia: Other Approaches to Leverage the Apoptotic Pathway

Clinical Lymphoma Myeloma & Leukemia(2022)10.1016/j.clml.2022.04.001

N/A

0DataRank · unranked

13 citations

Bing Z. Carter, Michael Andreeff, Marina Konopleva, Abhishek Maiti

C-MYC Targeting by Degradation: Novel Dual c-Myc/GSPT1 Degrader GT19715 Exerts Profound Cell Kill in vitro and in vivo in Acute Myeloid Leukemia and Lymphomas

(2022)10.52519/00071

N/A

0DataRank · unranked

1 citations

Darah A. Scruggs, Edward Ayoub, Tallie Patsilevas, Lauren B. Ostermann, Vivian Ruvolo +10 more

Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia

Cancer Discovery(2023)10.1158/2159-8290.cd-22-0601

N/A

0DataRank · unranked

78 citations

Xufeng Chen, Emmanouil Zacharioudakis, Wafa Al-Santli, Hua Zhou, Bettina Nadorp +16 more

Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells

Haematologica(2023)10.3324/haematol.2022.281915

N/A

0DataRank · unranked

68 citations

Lina Han, Cassandra L. Ramage, Zhe Wang, Connie C. Weng, Lei Yang +15 more

Mitochondrial regulation of GPX4 inhibition–mediated ferroptosis in acute myeloid leukemia

Leukemia(2023)10.1038/s41375-023-02117-2

N/A

0DataRank · unranked

50 citations

Ran Zhao, Lauren B. Ostermann, Ziyi Li, Matthew Tcheng, Samar J. Yazdani +13 more

Molecular Mechanisms of Ferroptosis and Updates of Ferroptosis Studies in Cancers and Leukemia

Cells(2023)10.3390/cells12081128

N/A

0DataRank · unranked

41 citations

Bing Z. Carter, Michael Andreeff, Jo Ishizawa, Hiroki Akiyama

Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-22-0343

N/A

0DataRank · unranked

16 citations

Sujan Piya, Huaxian Ma, Priyanka Sharma, Qi Zhang, Natalia Baran +10 more

Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity

Blood Advances(2023)10.1182/bloodadvances.2022009391

N/A

0DataRank · unranked

29 citations

Tapan M. Kadia, Nicholas J. Short, Gautam Borthakur, Sa A. Wang, Wei Wang +22 more

Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation

Cancer(2023)10.1002/cncr.34728

N/A

0DataRank · unranked

20 citations

Hagop M. Kantarjian, Nicholas J. Short, Wei Qiao, Jing Ning, Branko Cuglievan +12 more

FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML

Leukemia(2023)10.1038/s41375-023-01897-x

N/A

0DataRank · unranked

19 citations

Weiguo Zhang, Mahesh Basyal, Kyung Hee Chang, Lauren B. Ostermann, Jared K. Burks +11 more

Mdm2/p53 levels in bone marrow mesenchymal stromal cells are essential for maintaining the hematopoietic niche in response to DNA damage

Cell Death and Disease(2023)10.1038/s41419-023-05844-7

N/A

0DataRank · unranked

5 citations

Rafael Heinz Montoya, Zoe Alaniz, Lauren B. Ostermann, Patrick P. Lin, Bin Liu +4 more

Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model

Haematologica(2023)10.3324/haematol.2022.281927

N/A

0DataRank · unranked

5 citations

Po Yee Mak, Wenjing Tao, Lauren B. Ostermann, Duncan H. Mak, Baozhen Ke +4 more

Cigarette smoke exposure accelerates AML progression in FLT3-ITD models

Blood Advances(2023)10.1182/bloodadvances.2023010111

N/A

0DataRank · unranked

2 citations

Huaxian Ma, Mansour Alfayez, Daniel E. Morales-Mantilla, Fei Wang, Yue Lu +10 more

Data from 1,25-Dihydroxyvitamin D3 Enhances the Apoptotic Activity of MDM2 Antagonist Nutlin-3a in Acute Myeloid Leukemia Cells Expressing Wild-type p53

(2023)10.1158/1535-7163.c.6531473

N/A

0DataRank · unranked

0 citations

Michael Andreeff, George P. Studzinski, Lyubomir T. Vassilev, Thelma Thompson

Data from The Novel Tryptamine Derivative JNJ-26854165 Induces Wild-Type p53- and E2F1-Mediated Apoptosis in Acute Myeloid and Lymphoid Leukemias

(2023)10.1158/1535-7163.c.6532173

N/A

0DataRank · unranked

0 citations

Jared K. Burks, Janine Arts, Michael Andreeff, Kensuke Kojima

Data from 1,25-Dihydroxyvitamin D3 Enhances the Apoptotic Activity of MDM2 Antagonist Nutlin-3a in Acute Myeloid Leukemia Cells Expressing Wild-type p53

(2023)10.1158/1535-7163.c.6531473.v1

N/A

0DataRank · unranked

0 citations

Michael Andreeff, George P. Studzinski, Lyubomir T. Vassilev, Thelma Thompson

Data from The Novel Tryptamine Derivative JNJ-26854165 Induces Wild-Type p53- and E2F1-Mediated Apoptosis in Acute Myeloid and Lymphoid Leukemias

(2023)10.1158/1535-7163.c.6532173.v1

N/A

0DataRank · unranked

0 citations

Jared K. Burks, Janine Arts, Michael Andreeff, Kensuke Kojima

Data from Activation of FOXO3a Is Sufficient to Reverse Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor Chemoresistance in Human Cancer

(2023)10.1158/0008-5472.c.6500598

N/A

0DataRank · unranked

0 citations

Chun-Ju Chang, Weiya Xia, Yan Wang, Kwok‐Kin Wong, Jeffrey A. Engelman +5 more

Data from Blockade of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase and Murine Double Minute Synergistically Induces Apoptosis in Acute Myeloid Leukemia via BH3-Only Proteins Puma and Bim

(2023)10.1158/0008-5472.c.6500051.v1

N/A

0DataRank · unranked

0 citations

Marina Konopleva, Jared K. Burks, Karen C. Dywer, Wendy Schober, Jer‐Yen Yang +4 more

Data from Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance

(2023)10.1158/1078-0432.c.6517552

N/A

0DataRank · unranked

0 citations

Ming Tan, Wen‐Chien Huang, Ping Li, Hua Guo, Ling‐Ming Tseng +7 more

Data from Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance

(2023)10.1158/1078-0432.c.6517552.v1

N/A

0DataRank · unranked

0 citations

Ming Tan, Wen‐Chien Huang, Ping Li, Hua Guo, Ling‐Ming Tseng +7 more

Data from Omental Adipose Tissue–Derived Stromal Cells Promote Vascularization and Growth of Endometrial Tumors

(2023)10.1158/1078-0432.c.6519938.v1

N/A

0DataRank · unranked

0 citations

Yan Zhang, Travis Solley, Felipe Amaya‐Manzanares, Frank C. Marini, Michael Andreeff +7 more

Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study

Haematologica(2024)10.3324/haematol.2023.284078

N/A

0DataRank · unranked

15 citations

Lucia Masárová, Naveen Pemmaraju, Sharon Bledsoe, Naval Daver, Elias Jabbour +19 more

Sample multiplexing in CyTOF: Path to optimize single-cell proteomic profiling

Cell Signaling(2024)10.46439/signaling.2.041

N/A

0DataRank · unranked

3 citations

Michael Andreeff, Muharrem Müftüoğlu

Age-specific induction of mutant p53 drives clonal hematopoiesis and acute myeloid leukemia in adult mice

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101558

N/A

0DataRank · unranked

5 citations

Rafael Heinz Montoya, Hiroki Akiyama, Lauren B. Ostermann, Shayuan Khazaei, Muharrem Müftüoğlu +9 more

Phase 1b/2 Study of Magrolimab (Magro), Azacitidine (AZA) and Venetoclax (VEN) in Patients (pts) with Newly Diagnosed (ND) Older/Unfit or High Risk Acute Myeloid Leukemia (AML) and Relapsed Refractory (R/R) AML: Final Clinical Data and Genomic Markers of Resistance/Relapse

Blood(2024)10.1182/blood-2024-203706

N/A

0DataRank · unranked

5 citations

Jayastu Senapati, Sanam Loghavi, Patrick K. Reville, Bofei Wang, Tapan M. Kadia +21 more

Protocol for monitoring clonal hematopoiesis in transgenic mouse models using multispectral imaging

STAR Protocols(2024)10.1016/j.xpro.2024.103362

N/A

0DataRank · unranked

0 citations

Lauren B. Ostermann, Shayaun Khazaei, Ran Zhao, Michael Andreeff, Rasoul Pourebrahim +1 more

A Phase II Trial of Azacitidine with Ipilimumab, Nivolumab, or Ipilimumab and Nivolumab with or without Azacitidine in Relapsed or Refractory Myelodysplastic Syndrome

Blood(2024)10.1182/blood-2024-205186

N/A

0DataRank · unranked

0 citations

Guillermo Montalban‐Bravo, Koji Sasaki, Naval Daver, Elias Jabbour, Yesid Alvarado Valero +15 more

Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0229

N/A

0DataRank · unranked

15 citations

Jayastu Senapati, Hagop M. Kantarjian, Bofei Wang, Patrick K. Reville, Sanam Loghavi +21 more

PPARγ-induced upregulation of fatty acid metabolism confers resistance to venetoclax and decitabine therapy in AML

Blood Neoplasia(2025)10.1016/j.bneo.2025.100121

N/A

0DataRank · unranked

3 citations

Tatsuro Watanabe, Kaori Saito, Abdullah Khasawneh, Abhishek Maiti, Zhihong Zeng +10 more

Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia

Blood Cancer Journal(2025)10.1038/s41408-025-01266-0

N/A

0DataRank · unranked

3 citations

Yuki Nishida, Kyung Hee Chang, Andrea Bedoy, Muharrem Müftüoğlu, Wencai Ma +13 more

Protocol for isolation of lipid droplets and mitochondria from acute myeloid leukemia cells for lipidomic analysis

STAR Protocols(2025)10.1016/j.xpro.2025.104257

N/A

0DataRank · unranked

1 citations

Liang Zhang, Shuxin Dong, Kazuharu Kamachi, Saurabh Kumar Gupta, Hiroki Akiyama +6 more

A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome

Haematologica(2025)10.3324/haematol.2024.286559

N/A

0DataRank · unranked

2 citations

Guillermo Montalban‐Bravo, Koji Sasaki, Naval Daver, Elias Jabbour, Yesid Alvarado +19 more

Dual MYC and GSPT1 Protein Degrader for MYC-Driven Cancers

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.24.650490

N/A

0DataRank · unranked

0 citations

Valeria Impedovo, Edward Ayoub, Natalia Baran, Darah A. Scruggs, Hideaki Mizuno +21 more

Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia

Blood Advances(2020)10.1182/bloodadvances.2020003120

N/A

0DataRank · unranked

182 citations

Guillermo Montalban‐Bravo, Hyunsoo Hwang, Jing Ning, Miguel Franquiz, Rashmi Kanagal‐Shamanna +12 more

Targeting GD2 with naxitamab overcomes GD3 synthase-driven immune suppression in triple-negative breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00843-7

N/A

0DataRank · unranked

0 citations

Bolutyfe Oderinde, Maryam Siddiqui, Anudishi Tyagi, Jenny Borgman, Chong Wu +3 more

Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens

Haematologica(2020)10.3324/haematol.2020.252569

N/A

0DataRank · unranked

174 citations

Caitlin R. Rausch, Jörge E. Cortes, Naveen Pemmaraju, Naval Daver, Farhad Ravandi +30 more

Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

Nature Communications(2020)10.1038/s41467-020-19119-8

N/A

0DataRank · unranked

391 citations

Feng Wang, Katharina Jahn, Tianyuan Hu, Tomoyuki Tanaka, Yuya Sasaki +28 more

Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and re-sensitizes acute myeloid leukemia to BCL-2 inhibition

Haematologica(2020)10.3324/haematol.2020.260331

N/A

0DataRank · unranked

123 citations

Po Yee Mak, Wenjing Tao, Marc O. Warmoes, Philip L. Lorenzi, Duncan H. Mak +6 more

Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment‐related mortality

American Journal of Hematology(2020)10.1002/ajh.26061

N/A

0DataRank · unranked

103 citations

Wei Qiao, Koji Sasaki, Farhad Ravandi, Tapan M. Kadia, Elias Jabbour +26 more

A Surge of DNA Damage Links Transcriptional Reprogramming and Hematopoietic Deficit in Fanconi Anemia

Molecular Cell(2020)10.1016/j.molcel.2020.11.040

N/A

0DataRank · unranked

52 citations

Rui Wang, Moon Jong Kim, Qianghua Hu, Chih-Chao Hsu, Jun Yao +17 more

Inhibition of Oxidative Phosphorylation Reverses Bone Marrow Hypoxia Visualized in Imageable Syngeneic B-ALL Mouse Model

Frontiers in Oncology(2020)10.3389/fonc.2020.00991

N/A

0DataRank · unranked

18 citations

Karine G. Harutyunyan, Natalia Baran, Saradhi Mallampati, Malgorzata Anna Zal, Antonio Cavazos +9 more

Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-β-p38-ALDH2 pathway

PLoS ONE(2020)10.1371/journal.pone.0242809

N/A

0DataRank · unranked

36 citations

Fouad El Dana, Stanley Ly, Yuanqing Yan, Vivian Ruvolo, Elizabeth J. Shpall +4 more

Clinical value of event-free survival in acute myeloid leukemia

Blood Advances(2020)10.1182/bloodadvances.2019001150

N/A

0DataRank · unranked

7 citations

Hagop M. Kantarjian, Vinita Popat, Gautam Borthakur, Guillermo Garcia‐Manero, Marina Konopleva +16 more